Terra L. Reeder

CHIC2 deletion, a surrogate for FIP1L1-PDGFRA fusion, occurs in systemic mastocytosis associated with eosinophilia and predicts response to imatinib mesylate therapy

Animesh Pardanani, Rhett P. Ketterling, Stephanie R. Brockman et al. · Blood · 2003 · 396 citations · Full text

Life Sciences, Immunology, Molecular Genetics +11

A phase 2 trial of combination low-dose thalidomide and prednisone for the treatment of myelofibrosis with myeloid metaplasia

Ruben A. Mesa, David P. Steensma, Animesh Pardanani et al. · Blood · 2003 · 279 citations · Full text

Medicine, Hematology, Pharmacology +10

Imatinib for systemic mast-cell disease

Animesh Pardanani, Michelle A. Elliott, Terra L. Reeder et al. · The Lancet · 2003 · 252 citations

Life Sciences, Oncology, Pharmacotherapy +10

Imatinib therapy for hypereosinophilic syndrome and other eosinophilic disorders

Animesh Pardanani, Terra L. Reeder, Luis F. Porrata et al. · Blood · 2003 · 225 citations

Life Sciences, Internal Medicine, Pharmacotherapy +16

Eosinophils are derived from the neoplastic clone in patients with systemic mastocytosis and eosinophilia

Animesh Pardanani, Terra L. Reeder, Chin‐Yang Li et al. · Leukemia Research · 2003 · 87 citations

Life Sciences, Oncology, Pathology +9